Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / AUTL - Autolus Therapeutics plc (AUTL) Q4 2023 Earnings Call Transcript


AUTL - Autolus Therapeutics plc (AUTL) Q4 2023 Earnings Call Transcript

2024-03-15 05:23:07 ET

Autolus Therapeutics plc (AUTL)

Q4 2023 Earnings Conference Call

March 14, 2024, 08:30 AM ET

Company Participants

Olivia Manser - Investor Relations

Christian Itin - Chief Executive Officer

Rob Dolski - Chief Financial Officer

Conference Call Participants

James Shin - Deutsche Bank

Gil Blum - Needham & Company

Eric Yeung - William Blair

Yanan Zhu - Wells Fargo

Jacob Mekhael - KBC Securities

Presentation

Operator

Hello, ladies and gentlemen, and welcome to the Autolus Therapeutics' Call to discuss the Full Year 2023 Financial Results and Business Updates. [Operator Instructions] As a reminder, this conference call is being recorded.

I would now like to turn the conference over to your host, Olivia Manser. Please go ahead.

Olivia Manser

Thanks, Michelle. Good morning or good afternoon, everyone. Thanks for joining us on today's call.

With me are Dr. Christian Itin, our Chief Executive Officer; and Rob Dolski, our Chief Financial Officer.

So, on Slide 2, before we begin, I'd just like to remind you that during today's call we will make statements related to our business that are forward-looking under federal securities laws and the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These may include, but are not limited to, statements regarding the status of clinical trials and development and for regulatory timelines for our product candidates and our expectations regarding our cash runway.

These statements are subject to a variety of risks and uncertainties that could cause actual results to differ materially from expectations and reflect our views only as of today. We assume no obligation to update any such forward-looking statements. For a discussion of the material risks and uncertainties that could affect our actual results, please refer to the risks identified in today's press release and our SEC filings, both available on the Investors section of our website....

For further details see:

Autolus Therapeutics plc (AUTL) Q4 2023 Earnings Call Transcript
Stock Information

Company Name: Autolus Therapeutics plc
Stock Symbol: AUTL
Market: NASDAQ
Website: autolus.com

Menu

AUTL AUTL Quote AUTL Short AUTL News AUTL Articles AUTL Message Board
Get AUTL Alerts

News, Short Squeeze, Breakout and More Instantly...